Gilead

A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
FDA Approves New Gilead Medication for HIV Prevention Study
WSJ Online
Thu, 07/19/12 - 07:41 am
FDA
HIV
Gilead
Truvada
Gilead Faces Big Issues With AIDS Vaccine
Seeking Alpha
Tue, 07/17/12 - 12:22 pm
Truvada
HIV
AIDS
Gilead
vaccines
Gilead Wins U.S. Approval For First HIV Prevention Pill
Bloomberg
Mon, 07/16/12 - 01:41 pm
Gilead
HIV
AIDS
Truvada
Can These 3 Companies Take Down Gilead?
Motley Fool
Thu, 07/12/12 - 11:27 am
Gilead
HIV
ViiV Healthcare
Shionogi
Merck
Bristol-Myers Squibb
Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla In Test
Bloomberg
Wed, 07/11/12 - 10:19 am
GSK
HIV
AIDS
Shionogi
Gilead
Atripla
Dolutegravir
3 Things to Watch With Gilead Sciences
Motley Fool
Tue, 07/10/12 - 11:13 am
Gilead
patents
hepatitis C
Why A Change In A Bristol-Myers Hepatitis C Trial Has Big Implications
Forbes
Fri, 06/29/12 - 09:25 am
hepatitis C
Bristol-Myers Squibb
Gilead
NS5A Inhibitors
daclatasvir
Gilead Submits New Drug Application to U.S. FDA for Boosting Agent Cobicistat
Yahoo
Thu, 06/28/12 - 06:13 pm
FDA
Gilead
cobicistat
Bristol Hep C Trial Change Has Big Implications
Pharmalot
Wed, 06/20/12 - 12:31 pm
hepatitis C
Bristol-Myers Squibb
clinical trials
Gilead
NS5A Inhibitors
declatasvir
Bristol CEO says Gilead holding out on hep C tie-up
Fierce Biotech
Fri, 06/1/12 - 12:30 pm
Bristol-Myers Squibb
Gilead
hepatitis C
Lamberto Andreotti
daclatasvir
GS-7977
High Profitability and Low Valuation for Gilead
Motley Fool
Mon, 05/28/12 - 11:19 am
Gilead
Gilead’s Pill Wins U.S. Panel Backing to Prevent HIV
Bloomberg
Fri, 05/11/12 - 11:18 am
Gilead
HIV
Truvada
1 Biotech With 2 Binary Events in 2 Days
Motley Fool
Thu, 05/10/12 - 11:07 am
Gilead
HIV
Truvada
Quad
Gilead’s Quad Pill Raises Kidney Questions, FDA Says
Bloomberg
Wed, 05/9/12 - 10:54 am
Quad
FDA
HIV
Gilead
Gilead’s Truvada Pill Is Safe for HIV Prevention, FDA Says
Bloomberg
Tue, 05/8/12 - 10:57 am
Gilead
Truvada
HIV
FDA
Truvada up for FDA debate as HIV preventive
Fierce Pharma
Mon, 05/7/12 - 12:17 pm
HIV
Truvada
FDA
Gilead
Roche's Pain May Be Merck's Gain
Seeking Alpha
Mon, 05/7/12 - 11:16 am
Roche
Merck
dalcetrapib
Abbott Laboratories
Bristol-Myers Squibb
Gilead
Eli Lilly
Pfizer
Sanofi
Illumina
26 Drugs Facing FDA Approval in 2012
TheStreet.com
Wed, 05/2/12 - 11:12 am
drug approvals
FDA
Regeneron
ONYX Pharmaceuticals
Pfizer
Celgene
Arena Pharmaceuticals
Alexa
Gilead
Merck
Ironwood
Vivus
Navidea Biopharmaceuticals
NPS Pharmaceuticals
Raptor Pharmaceuticals
Santarus
Biogen Idec
Higher Costs Hurt Gilead
Yahoo/Zacks
Fri, 04/27/12 - 11:09 am
Gilead
earnings

Pages